Navigation
Market Outlook Stock Screener Dividend Calendar Event Calendar Rating of shares Markets News
Try free

Co-Diagnostics

NASDAQ CODX
$1.12 0.0000 0.0000%
Today share price
USA
Sector: Healthcare Industry: Health Care Equipment & Supplies
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Index: 14 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

33.42M
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
19.35M
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.
-1.78
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.
29.84M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.
-15.79 %

Upcoming events Co-Diagnostics

All events
No upcoming events scheduled

Overview

Financials

Key Metrics

Dividends

Industry overview

Events

Stock chart Co-Diagnostics

Stock analysis Co-Diagnostics

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

More
-0.86 55.02
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

More
0.39 18.61
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

More
-0.46 39.51
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

More
0.34 0.81
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

More
-49.63 18.00

Price change Co-Diagnostics per year

7.01$ 20.69$
Min Max

Summary analysis Co-Diagnostics

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Co-Diagnostics

Revenue and net income Co-Diagnostics

All parameters

Stock news Co-Diagnostics

All news
27 December 2023 в 20:45

Co-Diagnostics Shares Rise 21% After Submitting FDA Application For Covid-19 Test Platform

27 December 2023 в 20:45

Co-Diagnostics Shares Rise 21% After Submitting FDA Application For Covid-19 Test Platform

12 August 2022 в 20:50

Co-Diagnostics downgraded to neutral from buy at Sidoti & Co.

12 August 2022 в 15:16

Co-Diagnostics Shares Tumble on Weak Earnings

12 August 2022 в 15:16

Co-Diagnostics Shares Tumble on Weak Earnings

11 July 2022 в 16:51

Co-Diagnostics Shares Up 5% Following Shipment of Monkeypox Virus Testing Reagent

11 July 2022 в 16:51

Co-Diagnostics Shares Up 5% Following Shipment of Monkeypox Virus Testing Reagent

27 May 2022 в 20:26

Co-Diagnostics Shares Continue Rise, Up 16%

27 May 2022 в 20:22

Co-Diagnostics Shares Continue Rise, Up 16%

26 May 2022 в 17:31

Co-Diagnostics Shares Rise 10% After Completing Principal Design of Test for Monkeypox Virus

26 May 2022 в 17:31

Co-Diagnostics Shares Rise 10% After Completing Principal Design of Test for Monkeypox Virus

24 March 2022 в 23:32

Co-Diagnostics Inc. Rises on 2021 Results Driven by Covid-19 Test Sales

24 March 2022 в 23:25

Co-Diagnostics Inc. Rises on 2021 Results Driven by Covid-19 Test Sales

15 March 2022 в 17:01

Co-Diagnostics Shares Climb on Buyback Program

15 March 2022 в 17:01

Co-Diagnostics Shares Climb on Buyback Program

21 September 2021 в 16:55

Co-Diagnostics' Logix Smart Flu/Covid-19 Test Gets Mexico Approval

21 September 2021 в 16:55

Co-Diagnostics' Logix Smart Flu/Covid-19 Test Gets Mexico Approval

5 March 2020 в 16:33

Лидеры и аутсайдеры Уолл-cтрит: La-Z-Boy, Co-Diagnostics, Seanergy Maritime Holdings

27 January 2020 в 16:36

Лидеры и аутсайдеры Уолл-cтрит: Co-Diagnostics, Allied Healthcare Products, NeuroMetrix

23 January 2020 в 16:23

Лидеры и аутсайдеры Уолл-cтрит: Marinemax, Co-Diagnostics, Innovate Biopharmaceuticals

About company Co-Diagnostics

Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and C, human papilloma virus, malaria, chikungunya, dengue, and the zika virus; three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; and liquid biopsy test for cancer screening. The company also provides tests that identify genetic traits in plant and animal genomes. In addition, it intends to sell diagnostic equipment from other manufacturers as self-contained lab systems. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.
Address:
2401 South Foothill Drive, Salt Lake City, UT, United States, 84109
Company name: Co-Diagnostics
Issuer ticker: CODX
ISIN: US1897631057
Country: USA
Exchange: NASDAQ
Currency: $
IPO date: 2017-07-12
Sector: Healthcare
Industry: Health Care Equipment & Supplies
Site: https://www.codiagnostics.com

On which stock exchange are Co-Diagnostics (CODX) stocks traded?

Co-Diagnostics (CODX) stocks are traded on NASDAQ.

What is the ticker of Co-Diagnostics stocks (CODX)?

The stock ticker of Co-Diagnostics’s stocks or in other words, the code is CODX. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does Co-Diagnostics (CODX) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Co-Diagnostics (CODX) belongs to the «Healthcare» sector and the «Health Care Equipment & Supplies» industry.

In what currency are Co-Diagnostics (CODX) stocks traded?

Co-Diagnostics (CODX) stocks are traded on the NASDAQ exchange in dollars.

What is the price of Co-Diagnostics (CODX) stocks today?

The current price of Co-Diagnostics stocks on 16.05.2024 is 1.12 dollars. per share.

What is the dynamics of Co-Diagnostics (CODX) stocks from the beginning of the year?

Co-Diagnostics (CODX) quotes have increased by -21.13% from the beginning of the year up to 1.12 dollars. per 1 stocks.

How much did Co-Diagnostics (CODX) stocks increase in мае 2024?

This month Co-Diagnostics (CODX) quotes have increased by -5.88% to 1.12 dollars. per share.

How much are Co-Diagnostics (CODX) stocks worth?

Today, on October, 16.05.2024 Co-Diagnostics’s (CODX) stocks cost 1.12 dollars..

What is the market capitalization of Co-Diagnostics (CODX)?

Capitalization is the market value of Co-Diagnostics (CODX) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 16.05.2024, the market capitalization of Co-Diagnostics (CODX) is estimated at about 33424019 dollars.